STADA Arzneimittel AG (STAGn.DE)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2017||Chairman of the Executive Board, Chief Executive Officer|
|67||2017||Chairman of the Supervisory Board|
|38||2016||Deputy Chairman of the Supervisory Board, Employee Representative|
|2017||Chief Financial Officer, Member of the Executive Board|
|2017||Managing Director of OTC segment|
- BRIEF-STADA Says On Track To Meet Targets After Q1 Results
- BRIEF-STADA Says Miguel Pagan To Become Head of Production
- BRIEF-Board Of STADA To File Application Related To Change Of Sub-Segment Of Stock Exchange
- BRIEF-STADA Arzneimittel: Domination And Profit And Loss Transfer Agreement Takes Effect
- BRIEF-STADA Says Domination And Profit And Loss Transfer Agreement With Nidda Healthcare GmbH Takes Effect